Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-21 Sale | 2024-03-25 5:30 pm | Arcellx Inc. | ACLX | Carroll Jill Director | 504,263 | $70.55 | $35,575,755 | 1,479,148 (Indirect) | View |
| 2023-12-14 Sale | 2023-12-18 4:47 pm | Arcellx Inc. | ACLX | Carroll Jill Director | 504,263 | $49.13 | $24,774,441 | 1,983,411 (Indirect) | View |
| 2023-05-31 Sale | 2023-06-02 4:56 pm | Arcellx Inc. | ACLX | Carroll Jill Director | 340,720 | $41.71 | $14,212,623 | 2,487,674 (Indirect) | View |
| 2023-05-11 Sale | 2023-05-15 6:18 pm | Arcellx Inc. | ACLX | Carroll Jill Director | 638,417 | $45.01 | $28,736,223 | 2,828,394 (Indirect) | View |
| 2022-02-08 Purchase | 2022-02-09 5:51 pm | Arcellx Inc. | ACLX | Carroll Jill Director | 1,666,667 | $15 | $25,000,005 | 2,033,196 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-21 7:47 pm | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 361,111 | $18 | $6,499,998 | 2,262,301 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-28 Option Award | 2024-06-06 4:52 pm | N/A 2034-05-28 | Arcellx Inc. | ACLX | Carroll Jill Director | 8,011 | $0 | 8,011 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:05 pm | N/A 2033-06-14 | Arcellx Inc. | ACLX | Carroll Jill Director | 11,459 | $0 | 11,459 (Direct) | View |
| 2022-02-08 Conversion | 2022-02-09 5:51 pm | N/A N/A | Arcellx Inc. | ACLX | Carroll Jill Director | 7,233,484 | $0 | 2,033,196 (Indirect) | View |
Ownership | 2022-02-03 5:24 pm | N/A N/A | Arcellx Inc. | ACLX | Carroll Jill Director | 0 | $0 | 3,833,340 (Indirect) | View |
| 2021-04-01 Disposition | 2021-04-01 7:43 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 13,997 | $0 | 0 (Direct) | View |
| 2021-04-01 Equity Swap | 2021-04-01 7:43 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 5,674,221 | $60 | 0 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:47 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 11,510,727 | $0 | 2,262,301 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:47 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 13,997 | $0 | 2,262,301 (Indirect) | View |
Ownership | 2020-07-16 8:22 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 0 | $0 | 1,887,193 (Indirect) | View |